Peptide Nucleic Acid as Therapeutic Agent


With a repeating N-(2-aminoethyl)-glycine peptide backbone coupled to purine and pyrimidine nucleobases via a linker, PNA are synthetic analogues of DNA. PNA-based technology has received a lot of interest as a viable method for gene modification due to the unique qualities of PNA, including resistance to enzymatic digestion, increased bio stability, and excellent hybridization affinity toward DNA and RNA. However, inadequate intracellular absorption presents a significant obstacle to the use of PNA. To improve PNA delivery and ensure that it reaches the appropriate spot, some solutions have been devised


    Related Conference of Peptide Nucleic Acid as Therapeutic Agent

    July 14-15, 2025

    15th World Glycobiology Congress

    Berlin, Germany
    July 17-18, 2025

    16th International Conference on Biofuels and Bioenergy

    Amsterdam, Netherlands
    September 08-09, 2025

    23rd International Conference on Structural Biology

    Frankfurt, Germany

    Peptide Nucleic Acid as Therapeutic Agent Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in